VIEWRAY
ViewRay develops advanced radiation therapy technology for the treatment of cancer. It designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delive... red. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s increased target accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who would not previously have been considered radiation therapy candidates. ViewRay believes MRIdian will significantly improve the safety and efficacy of radiation therapy, leading to improved patient outcomes with reduced side effects from off-target radiation delivery. The company was incorporated in 2004 and is based in Cleveland, Ohio.
VIEWRAY
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
2004-01-01
Address:
Oakwood, Ohio, United States
Country:
United States
Website Url:
http://www.viewray.com
Total Employee:
251+
Status:
Active
Contact:
440-703-3210
Email Addresses:
[email protected]
Total Funding:
877.79 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content IPv6 ReCAPTCHA V2 Amazon Virginia Region Amazon S3 CDN AWS Global Accelerator Lorem Ipsum ASP.NET Ajax Akamai Hosted
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Acutus Medical
Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Bolt Threads
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.
CVRx
CVRx is a medical device company developing implantable technology for the treatment of high blood pressure.
Establishment Labs
Establishment Labs, the next generation breast aesthetics company,
HydraFacial
HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.
NeuroPace
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
SurModics
SurModics provides a surface modification and in vitro diagnostic technologies to the healthcare industry.
Vaxart
Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - ViewRay
MidCap Financial
MidCap Financial investment in Post-IPO Debt - ViewRay
Elekta
Elekta investment in Post-IPO Equity - ViewRay
Armentum Partners
Armentum Partners investment in Debt Financing - ViewRay
Acuta Capital Partners
Acuta Capital Partners investment in Post-IPO Equity - ViewRay
Puissance Capital
Puissance Capital investment in Post-IPO Equity - ViewRay
OrbiMed
OrbiMed investment in Post-IPO Equity - ViewRay
Kearny Venture Partners
Kearny Venture Partners investment in Post-IPO Equity - ViewRay
Xeraya Capital
Xeraya Capital investment in Post-IPO Equity - ViewRay
OrbiMed
OrbiMed investment in Post-IPO Equity - ViewRay
Key Employee Changes
Official Site Inspections
http://www.viewray.com Semrush global rank: 8.58 M Semrush visits lastest month: 509
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "ViewRay"
ViewRay, Inc. - Investor Relations
Jun 13, 2023 · ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients …See details»
The Collapse of ViewRay - Radiology Oncology Systems
Oct 13, 2023 · ViewRay’s MRIdian was the world’s first radiation therapy system to integrated diagnostic quality MRI. ViewRay’s journey to become a staple in the world of radiation oncology struggled from the onset.See details»
ViewRay Company Profile - Office Locations, Competitors ... - Craft
Aug 19, 2024 · ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system. Its solution integrates MRI technology, radiation …See details»
ViewRay - Crunchbase Company Profile & Funding
ViewRay develops advanced radiation therapy technology for the treatment of cancer. It designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system that can image and treat cancer patients simultaneously.See details»
ViewRay Company Profile 2024: Stock Performance & Earnings
ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures, and markets radiation therapy systems that provide real-time imaging during radiation …See details»
ViewRay, Inc. - AnnualReports.com
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique …See details»
ViewRay, Inc. Company Profile | Oakwood Village, OH
Find company research, competitor information, contact details & financial data for ViewRay, Inc. of Oakwood Village, OH. Get the latest business insights from Dun & Bradstreet.See details»
ViewRay, Inc. - LinkedIn
ViewRay®, Inc. (NASDAQ:VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system.See details»
ViewRay, Inc. - Governance - Executive Management
At ViewRay, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by …See details»
ViewRay, Inc.: Culture - LinkedIn
ViewRay®, Inc. (NASDAQ:VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system. ViewRay, Inc. | 24,548 followers on LinkedIn.See details»
ViewRay, Inc. - ViewRay Announces Preliminary Fourth Quarter …
DENVER, Jan. 9, 2023 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended …See details»
Open Letter to ViewRay Customers From Krishnan Suthanthiran, …
Oct 13, 2023 · Krishnan Suthanthiran offers a solution for continued support and service to ViewRay customers.See details»
ViewRay's Leadership Team Team - Team members and org chart
The leadership team at ViewRay has a history of experience in various fields including academia, business, and medicine.See details»
ViewRay - Funding, Financials, Valuation & Investors - Crunchbase
ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.See details»
ViewRay CEO and Key Executive Team | Craft.co
ViewRay's President, Chief Executive Officer & Director is Scott Drake. Other executives include Paul Ziegler, Executive Vice President and Chief Commercial Officer; James F. Dempsey, …See details»
ViewRay, Inc: Revolutionizing Radiation Therapy with Innovative ...
Jan 7, 2022 · ViewRay is a leading innovator in MRI-guided radiation therapy and aims to “Conquer cancer by re-envisioning technology.” IndustryWired has featured Scott Drake, CEO …See details»
ViewRay Announces Primary Endpoint Outcome from First …
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging …See details»
Working at ViewRay - Glassdoor
ViewRay, Inc (NASDAQ: VRAY), A New Kind of Medical Technology Company, was founded in 2004 on the belief that enhanced real-time visualization combined with on-line adapting and …See details»
ViewRay, Inc. - Governance - Committee Composition
At ViewRay, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by …See details»
ViewRay Climbing A Steep Hill As It Tries To Disrupt The Radiation ...
Jan 7, 2020 · Small-cap rad-onc company ViewRay (VRAY) certainly doesn't lack for ambition, as it is trying to disrupt the $5 billion radiation oncology equipment market with its MRI-guided …See details»